Biological impact of a disrupted estrogen receptor gene on estrogen- related cancer

Endocrine-Related Cancer

Volumn 4, Issue 4, 1997, Pages 387-406

  Bocchinfuso, W P ^a   Korach, K S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

BREAST CANCER; CELL PROLIFERATION; ENDOMETRIUM CANCER; GENE EXPRESSION; HORMONE RECEPTOR INTERACTION; HUMAN; MITOGENESIS; OVARY CANCER; REVIEW;

EID: 0030731762     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0040387     Document Type: Review

References (127)

1. 1-arrested human breast cancer cells. Oncogene 12 2315-2324.
2. Auchus RJ & Fuqua SAW 1994 The estrogen receptor. In Baillière's Clinical Endocrinology and Metabolism: Hormones, Enzymes and Receptors, pp 433-449. Eds MC Sheppard & PM Stewart. London: Baillière Tindall.
3. Barrett JC & Tsutsui T 1996 Mechanisms of estrogen-associated carcinogenesis. In Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, pp 105-111. Eds J Huff, J Boyd & JC Barrett. New York: Wiley-Liss.
4. Beato M 1996 Experimental models for endometrial cancer. In Hormone-Dependent Cancer, pp 453-475. Eds JR Pasqualini & BS Katzenellenbogen. New York: Marcel Dekker, Inc.
5. Berchuck A, Kohler MF & Bast Jr RC 1996 Molecular genetic features of ovarian cancer. In Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences. Eds J Huff, J Boyd & JC Barrett. New York: Wiley-Liss.
6. Berry M, Metzger D & Chambon P 1990 Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO Journal 9 2811-2818.
7. Bhanot P, Brin KM, Samos CH, Hsieh J-C, Wang Y, Macke JP, Andrew D, Nathans J and Nusse R 1996 A new member of the frizzled family from drosophila functions as a wingless receptor. Nature 382 225-230.
8. Bourguet W, Ruff M, Chambon P, Gronemeyer H & Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375 377-382.
9. Boyd J 1996 Estrogen as a carcinogen: the genetics and molecular biology of human endometrial carcinoma. In Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, pp 151-173. Eds J Huff, J Boyd & JC Barrett. New York: Wiley-Liss.
10. Bunone G, Briand P-A, Miksicek RJ & Picard D 1996 Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO Journal 15 2174-2183.
11. Byers M, Kuiper GGJM, Gustafsson J-A & Park-Sarge O-K 1997 Estrogen receptor-β mRNA expression in rat ovary: down regulation by gonadotropins. Molecular Endocrinology 11 172-182.
12. Canez MS, Lee KJ & Olive DL 1992 Progestogens and estrogens. In Infertility and Reproductive Medicine Clinics of North America: Sex Steroids, pp 59-78. Eds AA Luciano & DA Metzger. Philadelphia, PA: WB Saunders Co.
13. Castles CG & Fuqua SAW 1996 Alterations within the estrogen receptor in breast cancer. In Hormone-Dependent Cancer, pp 81-105. Eds JR Pasqualini & BS Katzenellenbogen. New York: Marcel Dekker, Inc.
14. Chalbos D, Philips A & Rochefort H 1994 Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues. Seminars in Cancer Biology 5 361-368.
15. Chatterjee VKK & Beck-Peccoz P 1994 Thyroid hormone resistance. In Baillière's Clinical Endocrinology and Metabolism: Hormones, Enzymes and Receptors, pp 267-283. Eds MC Sheppard & PM Stewart. London: Baillière Tindall.
16. Ciocca DR & Vargas Roig LM 1995 Estrogen receptors in human nontarget tissues: biological and clinical implications. Endocrine Reviews 16 35-62.
17. Clark JH, Schrader WT & O'Malley Jr. WC 1985 Mechanisms of steroid hormone action. In Textbook of Endocrinology, edn 7, pp 33-75. Eds JD Wilson & DW Foster. Philadelphia, PA: W B Saunders.
18. Coleman S, Silberstein GB & Daniel CW 1988 Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Developmental Biology 127 304-315.
19. Couse JF, Curtis SW, Washburn TF, Eddy EM, Schomberg DW & Korach KS 1995a Nuclear receptors in cell growth, death and inflammation. Biochemical Society Transactions 23 929-935.
20. Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O & Korach KS 1995b Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Molecular Endocrinology 9 1441-1454.
21. Couse JF, Davis VL & Korach KS 1996 Physiological findings from transgenic mouse models with altered levels of estrogen receptor expression. In Estrogens, Progestins, and Their Antagonists, vol 2, pp 69-98. Ed EJ Pavlik. Boston: Birkhauser.
22. Couse JF, Davis VL, Hanson RB, Jefferson WN, McLachlan JA, Bullock BC, Newbold RR & Korach KS 1997a Transgenic mice with aberrant expression of the estrogen receptor demonstrate accelerated onset of uterine tumors after neonatal exposure to diethylstilbestrol. Molecular Carcinogenesis 19 236-242.
23. Couse JF, Lindzey JK, Gustafsson J-A & Korach KS 1997b Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) mRNA in the wild-type and ERα-knockout mouse. Endocrinology (In Press).
24. Cunha GR & Hom YK 1996 Role of mesenchymeepithelial interactions in mammary gland development. Journal of Mammary Gland Biology and Neoplasia 1 21-35.
25. Cunha GR & Young P 1996 EGF receptor signaling plays different roles in estrogen-induced epithelial proliferation in mammary gland versus uterus. 10th International Congress of Endocrinology, San Francisco, CA, USA. San Francisco: The Endocrine Society Press.
26. Cunha GR, Cooke PS, Korach KS, Taylor JA & Lubahn DB 1996 Stromal estrogen receptors mediate the mitogenic effect of estradiol on uterine epithelium. 10th International Congress of Endocrinology, San Francisco, CA, USA. San Francisco: The Endocrine Society Press.
27. Curtis SW, Wasburn T, Charles S, DiAugustine R, Lindzey J, Couse JF & Korach KS 1996 Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proceedings of the National Academy of Sciences of the USA 93 12626-12630.
28. Daniel CW, Silberstein GB & Strickland P 1987 Direct action of 17β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Research 47 6052-6057.
29. Das R & Vonderhaar BK 1997 Prolactin as a mitogen in mammary cells. Journal of Mammary Gland Biology and Neoplasia 2 29-39.
30. Davis BJ & Maronpot RR 1996 Chemically associated toxicity and carcinogenicity of the ovary. In Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, pp 285-308. Eds J Huff, J Boyd & JC Barrett. New York: Wiley-Liss.
31. DiAugustine RP, Richards RG & Sebastian J 1997 EGF-related peptides and their receptors in mammary gland development. Journal of Mammary Gland Biology and Neoplasia 2 109-117.
32. Dickson RB & Lippman ME 1995 Growth factors in breast cancer. Endocrine Reviews 16 559-589.
33. Dukes M, Chester R, Yarwood L & Wakeling AE 1994 Effects of a non-steroidal pure antiestrogen, ZM 189,154, on oestrogen target organs of the rat including bones. Journal of Endocrinology 141 335-341.
34. Eddy EM, Wasburn TF, Bunch EH, Goulding EH, Gladen BC, Lubahn DB & Korach KS 1996 Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 137 4796-4805.
35. Emons G & Schulz K-D 1996 Growth regulation of epithelial ovarian cancer by hormones, peptide growth factors, and cytokines. In Hormone-Dependent Cancer. Eds JR Pasqualini & BS Katzenellenbogen. New York: Marcel Dekker, Inc.
36. Fantl V, Stamp G, Andrews A, Rosewell I & Dickson C 1995 Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes and Development 9 2364-2372.
37. Findlay JK 1991 The ovary. In Baillière's Clinical Endocrinology and Metabolism: Growth Factors in Endocrinology, pp 755-769. Eds DM Robertson & AC Herington. London: Baillière Tindall.
38. Gavin BJ & McMahon AP 1992 Differential regulation of the Wnt gene family during pregnancy and lactation suggests a role in postnatal development of the mammary gland. Molecular and Cellular Biology 12 2418-2423.
39. George FW & Wilson JD 1988 Sex determination and differentiation. In The Physiology of Reproduction, pp 3-26. Eds E Knobil, JD Neil, LL Ewing, GS Greenwald, CL Markert & DW Pfaff. New York: Raven Press.
40. Godfrey P, Rahal JO, Beamer WG, Copeland MG, Jenkins NA & Mayo KE 1993 GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nature Genetics 4 227-232.
41. Godwin AK, Testa JR & Hamilton TC 1993 The biology of ovarian cancer development. Cancer Supplement 71 530-536.
42. Greco TL, Duello TM & Gorski J 1993 Estrogen receptors, estradiol, and diethylstilbestrol in early development: the mouse as a model for the study of estrogen receptors and estrogen sensitivity in embryonic development of male and female reproductive tracts. Endocrine Reviews 1459-71.
43. Gumbiner BM 1995 Signal transduction by β-catenin. Current Opinion in Cell Biology 7 634-640.
44. Haslam SZ 1988 Acquisition of estrogen-dependent progesterone receptors by normal mouse mammary gland. Ontogeny of mammary progesterone receptors. Journal of Steroid Biochemistry 31 9-13.
45. Herbst AL, Ulfelder H & Poskanzer DC 1971 Adenocarcinoma of the vagina. New England Journal of Medicine 284 878-881.
46. Herbst AL, Cole R, Colton T, Robboy SJ & Scully RE 1977 Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. American Journal of Obstetrics and Gynecology 128 43-48.
47. Hewison M & O'Riordan JLH 1994 Vitamin D resistance. In Baillière's Clinical Endocrinology and Metabolism: Hormones, Enzymes and Receptors, pp 305-315. Eds MC Sheppard & PM Stewart. London: Baillière Tindall.
48. Hillier SG 1991 Introvarian steroid action. In New Biology of Steroid Hormones, pp 227-234. Eds RB Hochberg & F Naftolin. New York: Raven Press.
49. Hillier SG 1994 Current concepts of the roles of follicle stimulating hormone and luteinzing hormone. Human Reproduction 9 188-191.
50. Hillier SG, Whitelaw PF & Smyth CD 1994 Follicular estrogen: the 'two-cell, two-gonadotropin' model revisited. Molecular and Cellular Endocrinology 100 51-54.
51. Hinck L, Nathke IS, Papkoff J & Nelson WJ 1994 β-Catenin: a common target for the regulation of cell adhesion by Wnt-1 and Src signaling pathways. Trends in Biochemical Science 19 538-542.
52. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS & Lung L 1996 Nuclear receptor coactivators and corepressors. Molecular Endocrinology 10 1167-1177.
53. Hou Q, Paria BC, Mui C, Dey SK & Gorski J 1996 Immunolocalization of estrogen receptor protein in the mouse blastocyst during normal and delayed implantation. Proceedings of the National Academy of Sciences of the USA 93 2376-2381.
54. Hsueh AJW, Billig H & Tsafriri A 1994 Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocrine Reviews 15 707-724.
55. Hunter T 1997 Oncoprotein networks. Cell 88 333-346.
56. Hurst BS, Zilberstein M, Chou JY, Litman B, Stephens J & Leslie KK 1995 Estrogen receptors are present in human granulosa cells. Journal of Clinical Endocrinology and Metabolism 80 229-232.
57. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS & McLachlan JA 1993 Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Molecular Endocrinology 7 992-998.
58. Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA & Korach KS 1996 Peptide growth factor-cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C orestradiol. Endocrinology 137 1735-1744.
59. Jahnke GD & Barrett JC 1996 Environmental causes and molecular biology of breast cancer: future research directions. In Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, pp 455-469. Eds J Huff, J Boyd & JC Barrett. New York: Wiley-Liss.
60. Johns A, Freay AD, Fraser W, Korach KS & Rubanyi GM 1996 Disruption of estrogen receptor gene prevents 17β-estradiol-induced angiogenesis in transgenic mice. Endocrinology 137 4511-4513.
61. Jordan VC & Murphy CS 1990 Endocrine pharmacology of antiestrogens as antitumor agents. Endocrine Reviews 11 578-610.
62. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D & Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 1491-1494.
63. Katzenellenbogen JA, O'Malley BW & Katzenellenbogen BS 1996 Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Molecular Endocrinology 10 119-131.
64. Kenney JN & Dickson RB 1996 Growth factor and sex steroid interactions in breast cancer. Journal of Mammary Gland Biology and Neoplasia 1 189-198.
65. Keough EM & Wood BG 1979 Mammary gland development during pregnancy in the dwarf mouse mutant, little. Tissue and Cell 11 773-780.
66. Key TJA & Pike MC 1988 The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. European Journal of Cancer and Clinical Oncology 24 29-43.
67. Kleinberg DL 1997 Early mammary development: growth hormone and IGF-1. Journal of Mammary Gland Biology and Neoplasia 2 49-57.
68. Kommoss F 1996 Common epithelial ovarian cancer: endocrine factors, hormonal therapy, and new aspects concerning the expression of sex steroid receptors. In Hormone-Dependent Cancer, pp 541-572. Eds JR Pasqualini & BS Katzenellenbogen. New York: Marcel Dekker, Inc.
69. Korach KS 1994 Insights from the study of animals lacking functional estrogen receptor. Science 266 1524-1527.
70. Korach KS, Couse JF, Curtis SW, Wasburn TF, Lindzey JK, Kimbro KS, Eddy EM, Migliaccio S, Snedecker SM, Lubahn DB, Schomberg DW & Smith EP 1996 Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Progress in Hormone Research 51 159-188.
71. Korach KS, Davis VL, Curtis SW & Bocchinfuso WP 1997a Xenoestrogens and estrogen receptor action. In Endocrine Toxicology, edn 2, pp 181-211. Eds JA Thomas & HD Colby. Washington: Taylor & Francis.
72. Korach KS, Taki M & Kimbro KS 1997b The effects of estrogen receptor gene disruption on bone. In Proceedings of the 2nd International Symposium on Women's Health and Menopause: Risk Reduction Stratagies. Dordrecht, The Netherlands: Kluwer Academics Publishing.
73. Kraus WL & Katzenellenbogen BS 1993 Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists. Endocrinology 132 2371-2379.
74. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S & Gustafsson J-A 1996 Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences of the USA 93 5925-5930.
75. Kumar V & Chambon P 1988 The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55 145-156.
76. Kumar V, Green S, Stack G, Berry M, Jin JR & Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51 941-951.
77. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS & Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proceedings of the National Academy of Sciences of the USA 90 11162-11166.
78. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery Jr CA, Shymala G, Conneely OM & O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes and Development 9 2266-2278.
79. McLachlan JA & Newbold RR 1996 Cellular and molecular mechanisms of cancers of the uterus in animals. In Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, pp 175-182. Eds J Huff, J Boyd & JC Barrett. New York: Wiley-Liss.
80. McMahon AP 1992 The Wnt family of developmental regulators. Trends in Genetics 8 236-242.
81. Medina D 1996 The mammary gland: a unique organ for the study of development and tumorigenesis. Journal of Mammary Gland Biology and Neoplasia 1 5-19.
82. Metzger D, Ali S, Bornert JM & Chambon P 1995 Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. Journal of Biological Chemistry 270 9535-9542.
83. Mosselman S, Polman J & Dijkema R 1996 ERβ: identification and characterization of a novel human estrogen receptor. FEBS Letters 392 49-53.
84. Murphy LJ 1994 Growth factors and steroid hormone action in endometrial cancer. Journal of Steroid Biochemistry and Molecular Biology 48 419-423.
85. Musgrove EA, Hui R, Sweeney KJE, Watts CKW & Sutherland RL 1996 Cyclins and breast cancer. Journal of Mammary Gland Biology and Neoplasia 1 153-162.
86. Newbold RR & McLachlan JA 1996 Transplacental hormonal carcinogenesis: diethylstilbestrol as an example. In Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, pp 131-147. Eds J Huff, J Boyd & JC Barrett. New York: Wiley-Liss.
87. Nowakowski BE & Maurer RA 1994 Multiple Pit-1 binding sites facilitate estrogen responsiveness of the prolactin gene. Molecular Endocrinology 8 1742-1749.
88. Nulsen JC & Peluso JJ 1992 Regulation of ovarian steroid production. In Infertility and Reproductive Medicine Clinics of North America: Sex Steroids, pp 43-57. Eds AA Luciano & DA Metzger. Philadelphia, PA: WB Saunders.
89. Nusse R 1997 A versatile transcriptional effector of wingless signaling. Cell 89 321-323.
90. Nusse R & Varmus HE 1982 Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31 99-109.
91. Nusse R & Varmus HE 1992 Wnt genes. Cell 69 1073-1087.
92. Nusse R, van Ooyen A, Cox D, Fung YKT & Varmus HE 1984 Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307 131-136.
93. Ogawa S, Taylor JA, Lubahn DB, Korach KS & Pfaff DW 1996 Reversal of sex roles in genetic female mice by disruption of estrogen receptor gene. Neuroendocrinology 64 467-470.
94. Ogawa S, Lubahn DB, Korach KS & Pfaff DW 1997 Behavioral effects of estrogen receptor gene disruption in male mice. Proceedings of the National Academy of Sciences of the USA 94 1476-1481.
95. van Ooyen A & Nusse R 1984 Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein-encoding domain intact. Cell 39 233-240.
96. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N & Kelly PA 1997 Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes and Development 11 167-178.
97. Patterson MN, McPhaul MJ & Hughes IA 1994 Androgen insensitivity syndrome. In Baillière's Clinical Endocrinology and Metabolism: Hormones, Enzymes and Receptors, pp 379-404. Eds MC Sheppard & PM Stewart. London: Baillière Tindall.
98. Peifer M 1997 β-Catenin as oncogene: the smoking gun. Science 275 1732-1753.
99. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX & Slamon DJ 1995 HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10 2435-2446.
100. Rao BR & Slotman BJ 1991 Endocrine factors in common epithelial ovarian cancer. Endocrine Reviews 12 14-26.
101. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H & Moras D 1995 Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378 681-689.
102. Richards JS 1975 Estradiol receptor content in rat granulosa cells during follicular development: modification by estradiol and gonadotropins. Endocrinology 97 1174-1184.
103. Risma KA, Clay CM, Nett TM, Wagner T, Yun J & Nilson JH 1995 Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proceedings of the National Academy of Sciences of the USA 92 1322-1326.
104. Russo IH & Russo J 1996 Mammary gland neoplasia in long-term rodent studies. Environmental Health Perspectives 104 938-967.
105. Saceda M, Knabbe C, Dickson RB, Lippman ME, Bronzart D, Lindsay RL, Gottardis M & Martin MB 1991 Posttranscriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13 acetate. Journal of Biological Chemistry 266 17809-17814.
106. Scully KM, Gleiberman AS, Lindzey JK, Lubahn DB, Korach KS & Rosenfeld MG 1997 Role of estrogen receptor a in the anterior pituitary gland. Molecular Endocrinology 11 674-681.
107. Shoham Z, Jacobs HS & Insler V 1993 Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertility and Sterility 58 1153-1161.
108. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ & Weinberg RA 1995 Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82 621-630.
109. Silberstein GB, Van Horn K, Shymala G & Daniel CW 1994 Esential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 134 84-90.
110. Smith CL, Conneely OM & O'Malley BW 1995 Oestrogen receptor activation in the absence of ligand. Biochemical Society Transactions 23 935-939.
111. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB & Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man [sec comments]. New England Journal of Medicine 331 1056-1061.
112. Smith OW & Smith GVS 1949 Use of diethylstilbestrol to prevent fetal loss from complications of late pregnancy. New England Journal of Medicine 241 562-568.
113. Snedecker SM & DiAugustine RP 1996 Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland. In Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, pp 211-253. Eds J Huff, J Boyd & JC Barrett. New York: Wiley-Liss.
114. Snedecker SM, Brown CF & DiAugustine RP 1991 Expression and functional properties of transforming growth factor α and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proceedings of the National Academy of Sciences of the USA 88 276-280.
115. Stancel CM, Chiapetta C, Gardner RM, Kirkland JL, Lin TH, Lingham RB, Loose Mitchell DS, Mukku VR & Orengo CA 1990 Regulation of the uterine epidermal growth factor receptor by estrogen. Progress in Clinical and Biological Research 322 213-226.
116. Taylor ICA, Roy S & Varmus HE 1995a Over expression of the Sky receptor tyrosine kinase at the cell surface or in the cytoplasm results in ligand-independent activation. Oncogens 11 2619-2626.
117. Taylor ICA, Roy S, Yaswen P, Stampfer MR & Varmus HE 1995b Mouse mammary tumors express elevated levels of RNA encoding the murine homolog of SKY, a putative receptor tyrosine kinase. Journal of Biological Chemistry 270 6872-6880.
118. Teng CT, Pentecost BT, Chen YH, Newbold RR, Eddy EM & McLachlan JA 1989 Lactotransferrin gene expression in the mouse uterus and mammary gland. Endocrinology 124 992-999.
119. Terakawa N, Harada T, Minigawa Y, Kigawa J & Sato B 1996 Endometrial Cancer. In Hormone-Dependent Cancer, pp 477-498. Eds JR Pasqualini & BS Katzenellenbogen. New York: Marcel Dekker, Inc.
120. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F & Giguere V 1997 Cloning, chromosomal location, and functional analysis of the murine estrogen receptor β. Molecular Endocrinology 11 353-365.
121. Tsai MJ & O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annual Review of Biochemistry 63 451-486.
122. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T & Varmus HE 1988 Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55 619-625.
123. Tzukerman MT, Esty A, Santiso Mere D, Danielian P, Parker MG, Stein RB, Pike JW & McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Molecular Endocrinology 8 21-30.
124. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A & Schmidt EV 1994 Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 669-671.
125. Weber-Hall SJ, Phippard DJ, Niemeyer CC & Dale TC 1994 Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. Differentiation 57 205-214.
126. Yang-Snyder J, Miller JR, Brown JD, Lai C-J & Moon RT 1996 A frizzled homologue functions in a vertebrate Wnt signaling pathway. Current Biology 6 1302-1306.
127. Zwijsen RML, Wientjens E, Klompmaker R, van der Sman J, Bernards R & Michalides RJAM 1997 CDK-independent activation of estrogen receptor by cyclin D1. Cell 88 405-415.